Dr. Yaziji is the founder and Medical Director of Vitro Molecular Laboratories and the medical education organization Pathology Learning Centers. An international expert, Dr. Yaziji, American Board certified in anatomic pathology, clinical pathology and Cytopathology, is an Adjunct Clinical Professor at the University of Texas, MD Anderson Cancer Center. He received his M. D. degree from the University of Damascus in 1989, and completed a residency in Anatomic and Clinical Pathology at the University of Louisville in 1996, followed by two fellowships in Surgical Pathology and Breast Pathology at the University of Washington in 1997 and 1998. He also completed a third fellowship in Cytopathology at the MD Anderson Cancer Center in 1999. Since then, Dr. Yaziji has published numerous original clinical research studies in prestigious peer-reviewed journals and has given presentations to pathologists and oncologists throughout the United States and abroad. He serves on editorial boards of peer-reviewed journals and currently serves on the Board of Directors of the International Society of Applied Immunohistochemistry and Molecular Morphology (ISIMM). Through the ASCO/CAP and other oncology/pathology authorities, Dr. Yaziji participated in setting up testing guidelines on ER, HER2 and immunohistochemistry of cancer biomarker testing since 2008. Dr. Yaziji has been a practicing pathologist since 1999, providing diagnostic and expert consultative services to hospitals on a continuing basis.
Dr. Adrian Padurean Palmer is a physician based out of Fort Myers, Florida and his medical specialization is Pathology - Anatomic Pathology & Clinical Pathology. He practices in Fort Myers, Florida and has the professional credentials of M.D. More than 18 years’ experience in community and academic hospitals and health care systems including over ten years as director of hematology laboratories for the second largest healthcare system in Southeast Wisconsin, and medical director and hematopathologist with one of the largest cancer focused reference laboratory in the country. More than six years in hospital functions as member of credentialing committee, internal medicine committee, and electronic medical records implementation committee. Graduated from an MBA program in Healthcare Management at Loyola University Chicago. Formerly Chief of Pathology and Fresno VA Medical Center.
Dr. Carlos A. Ricotti, MD, is board-certified both in dermatology and dermatopathology by the American Boards of Dermatology and Pathology. He completed his residency in dermatology at the University of Miami, followed by a dermatopathology fellowship at University of Texas, Southwestern (UTSW) in Dallas.
Dr. Eisen is currently practicing, since 2015, in the Banner Health System, at Banner University and Thunderbird Medical Centers, in Phoenix and Glendale, AZ. He also teaches medical students at the University of Arizona Medical School, Phoenix Campus. He received his MD degree from SUNY Downstate in 1984 and received his post-graduate training in Internal Medicine and Pathology at Yale University, including a fellowship in Surgical Pathology under the directorship of Dr. Juan Rosai. He served on the full time Yale faculty until 1993, directing the Immunohistochemistry (IHC) Laboratory there for 2 years and the Anatomic Pathology and IHC laboratory sections at the Yale affiliate, Greenwich Hospital until 2015. Dr. Eisen has been involved with the Applied Immunohistochemistry and Molecular Morphology Retreat since its inaugural meeting in 2007, as faculty and assisting Dr. Hadi Yaziji in moderating and directing a subset of the courses. He has also served on the Board of Directors of The Society for Applied Immunohistochemistry from 1995 and as the Society’s President beginning in 1997. He is the current Chair of the IHC Committee for Banner-Laboratory Sciences of Arizona and maintains an interest in IHC, ENT, soft tissue, bone and hematopathology. Dr. Eisen also served as a member of the IHC Resource Committee of the College of American Pathologists (CAP) from 2004-2010 and remains an active member of both CAP and United States and Canadian Academy of Pathology. He has served as an advisor to the CAP Center Project on IHC Validation Guidelines and as a member of the CAP Center Project for Uniform Labeling Standards for Anatomic Pathology.